Formulations, Pharmacodynamic and Clinical Studies of Nanoparticles for Lung Cancer Therapy-An overview.

CONCLUSION: Nanoparticle delivery system for lung cancer therapy is still in its early stage and expecting numerous challenges.
PMID: 29512452 [PubMed - as supplied by publisher]

Source: Current Drug Metabolism - March 5, 2018 Category: Drugs & Pharmacology Authors: Zheng D, Wang J, Guo S, Zhao Z, Wang F Tags: Curr Drug Metab Source Type: research